Work

Exacerbation and mortality in COPD patients on triple inhaler and at high exacerbation risk

Year: 2024

Type: conference-abstract

Source: Epidemiology

DOI: 10.1183/13993003.congress-2024.pa1287

Authors: Clementine Nordon, Donna Carstens, Malin Fageras, Hana Mullerova, Amy Anderson, Phani Veeranki, Joao Andre Alves, Timothy Barnes, Meredith Mccormack

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States), AstraZeneca (Sweden), Optum (United States), Johns Hopkins University

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404101203

Cites:

Cited by: 2

Related to: 10